bearish•JD Health International •21 Aug 2023 08:55
JD Health (6618.HK) 23H1 - The Beautiful Story Is Over; It's Time to Face Reality
We had anticipated JD Health's declining growth in previous insights, but 23Q2 performance was indeed ugly. JD Health's facing dilemmas in policies...
bullish•JD Health International •18 Aug 2023 08:33
[JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show
With years of tightening NDRL and the recent hardline anti-corruption campaign, more pharmaceuticals and patients are looking for alternative...
bearish•JD Health International •17 Aug 2023 12:52
JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited
Though JD Health made an OPM of 5.7% in 1Q2023, 1H2023 OPM was 3.5% in line with our analysis that OPM in excess of 2-3% may not be possible in the...
bearish•JD Health International •09 Jun 2023 12:06
JD Health: Profitability Remains Under Pressure
JD Health reported an OPM of 5.7% for 1Q2023. Our quantamental analysis proves that this is one off and may not be able to generate OPM in excess...
bullish•JD Health International •16 May 2023 08:55